These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7451489)

  • 1. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
    Covey DF; Hood WF; Parikh VD
    J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of mechanism-based inactivators of human placental aromatase.
    Marcotte PA; Robinson CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3322s-3326s. PubMed ID: 7083194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
    Akkani A; Paterlini G; Gleason WB; Ojala WH; Abul-Hajj YJ
    J Med Chem; 1997 Sep; 40(20):3263-70. PubMed ID: 9379446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The constitutive 7-ethoxycoumarin O-deethylase activity of human placental microsomes: relationship to aromatase.
    Meigs RA
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1012-8. PubMed ID: 3496877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
    Miyairi S; Fishman J
    J Biol Chem; 1986 May; 261(15):6772-7. PubMed ID: 3700413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical studies of estr-4-ene-3,6,17-trione and 5 alpha-androstan-17-ones with or without a carbonyl function at C-3 and/or C-6 as aromatase inhibitors.
    Numazawa M; Mutsumi A; Tachibana M; Nagaoka M
    Biol Pharm Bull; 1995 Apr; 18(4):555-8. PubMed ID: 7655426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19-Hydroxy-4-androsten-17-one: potential competitive inhibitor of estrogen biosynthesis.
    Numazawa M; Mutsumi A; Hoshi K; Koike R
    Biochem Biophys Res Commun; 1989 May; 160(3):1009-14. PubMed ID: 2730636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
    Kruter RH; Berkovitz GD; Migeon CJ; Brown TR
    J Steroid Biochem; 1987 Aug; 28(2):139-45. PubMed ID: 3626551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity.
    Covey DF; Hood WF
    Endocrinology; 1981 Apr; 108(4):1597-9. PubMed ID: 7472286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors.
    Numazawa M; Tachibana M; Tateda Y
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):431-8. PubMed ID: 8903428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.